Inflammasomes, are macromolecular inflammatory signalling complexes activated by the detection of pathogenic microorganisms and process pro-inflammatory cytokines (i.e., pro–IL-1β and pro-IL-18) to their bioactive forms [78], have been investigated in COVID-19. The gene discussed is IL1B; the disease is COVID-19.